Harmony Biosciences Holdings, Inc. HRMY Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Harmony Biosciences Holdings, Inc.'s long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s long-term debt?
- Harmony Biosciences Holdings, Inc. (HRMY) reported long-term debt of $138.81M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s long-term debt changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s long-term debt decreased by 12.2% year-over-year, from $158.18M to $138.81M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s long-term debt?
- Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s long-term debt has grown at a -5.9% compound annual growth rate (CAGR), from $194.25M to $143.66M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.